<img src="https://secure.24-astute.com/796183.png" style="display:none;">

Proteros Company and History

Based in the Martinsried / Munich - Biotech Cluster in Germany with US presence in Boston and San Diego

Roots to the Max-Planck Institute of Biochemistry, Nobel Prize winning science

Early stage drug discovery services provider with cutting-edge discovery engine

Proven track record of successful business with global pharma and biotech companies

Positioned in growing drug discovery market

 

View our history

Our Management and Board Members

Torsten_bw

Dr. Torsten Neuefeind 

 

CHIEF Executive OFFICER

Proteros New Starters (1)-1

Dr. Ashiq H.
Khan 

 

CHIEF Commercial OFFICER

 

 

Our Values

Lamp

EXPERTISE

We are recognized as experts in our market of early drug discovery research. In a dynamic environment we have the will to always keep up with the latest developments. We apply our profound knowledge to the progress of our clients challenging projects.

Arrow

Excellence

Based on our profound expertise our ambition is excellence in science and business execution. We have the will to do better and not to accept the standard. We always strive to deliver the work that sets benchmarks in our market.

People Interaction

Agility

We are agile in thinking and the way we act. This requires flexibility, a can-do and service mentality. We are fully committed to our clients challenges and drive things forward proactively.

our Services

hit_timeline-img_CG (1)

Drug Discovery

  • Qualified Hits Programm
  • Discovery Your Way

.

40280_timeline-img_CG

X-Ray

  • Gallery Structures
  • Protein X-Ray Crystallography
  • cryo-EM

Proteros 1_timeline-img_CG

Cryo-em

  • Protein preparation for cryo-EM
  • EM feasibility analysis
  • cryo-EM condition optimization
  • Low-/high resolution cryo-EM structure analysis

49580 timeline-img_CG

Protein Sciences

  • Gallery Proteins
  • Gene-to-Proteins

.

21404370_timeline-img_CG

Biologics

  • Recombinant expression
  • Analytics-driven purification / QC
  • Structural analysis (X-Ray / cryo-EM)
  • Biophysical/biochemical interaction analysis
  • Early research developability assessment (non GxP)

Proteros_40002_timeline-img_CG

Assays, Biophysics & Screening

  • Gallery Assays
  • Customized Assay Development
  • Compound Profiling
  • Screening

Proteros by numbers

 

Proven track record with 200+ pharma and biotech partners in US, Europe and Japan

Serve most of the world's 20 largest pharma companies

Provide discovery support to hundreds of big, small and virtual biotechs

+0

structures elucidated

+0

projects completed

0

Peer-reviewed publications

Cutting edge facilities at the Martinsried biotech cluster in Munich

We are based in the Martinsried / Munich - Biotech Cluster in Germany. Our facility has been specifically designed to meet our specific service execution demands with dedicated floors and lab rooms for each Structural Biology, cryo-EM, Protein Sciences, Biologics and Assays, Biophysics and Screening, but everything still "under one roof" to foster the synergistic interaction required for Discovery Solutions and multi-disciplinary projects.

We are very close to our biotech neighbours, pharmaceutical, medical, pharmaceutical university, Max-Planck-Institutes and hospitals, which is very stimulative for scientific networking and translational activities.

The Munich Airport is within reach to connect us with superb routine flights into Europe, US and Japan. Come and visit us!

Proteros_40321_NTC_CG-1

News & events

Sept 06, 2023

News

Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with full chemistry support of Enamine

READ MORE

Jan 09, 2023

News

Proteros receives minority investment from private equity firm Inflexion

READ MORE

Oct 25, 2022

News

Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases

READ MORE

May 16, 2022

News

Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca

READ MORE